Have you participated in one of ACC's leadership development programs? Do you have a great story to share about how it impacted you? Submit your story for a chance to be the featured impact speaker at ...

With your help, ACC Advocacy actively works with Congress, state legislators, and other key decision makers to transform cardiovascular care and improve heart health. However, we need everyone's voice ...

In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...

Exposure to high levels of aircraft noise, especially at night, is associated with adverse cardiac remodeling in the form of concentric left ventricular (LV) hypertrophy and reduced LV systolic ...

We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. The updated ASCVD Risk Estimator Plus uses up-to-date ACC clinical policy and user ...

Cardiovascular medications frequently lead the polypharmacy category, often contributing to adverse clinical outcomes, and the most vulnerable among us are often prescribed the most complex regimens.

The focus of the Electrophysiology Section and Section Leadership Council is on the specialties of cardiac electrophysiology and electrocardiography and includes all aspects of management and ...

Patients with a history of cardiovascular disease, compared with those without, had a higher incidence of sudden cardiac death (SCD), according to a study of 5.5 million Danish citizens in 2010, ...

The ACC has issued new guidance on practical approaches for arrhythmia monitoring after stroke, offering clinicians tailored strategies to improve post-stroke care by identifying and managing atrial ...

Days alive out of health care and hospitalization (DAoH), a novel measure of outcomes in children undergoing cardiovascular surgery, offers advantages over the traditional outcome measure of days ...

Among patients with takotsubo syndrome (TTS), beta-blocker therapy was associated with lower follow-up mortality but not lower TTS recurrence, according to a study published Feb. 5 in JACC: Heart ...

MedAxiom recently released the 2024 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which shows how APP leadership roles are beginning to guide new team-based care ...